Insider Transactions in Q1 2022 at X4 Pharmaceuticals, Inc (XFOR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Derek M Meisner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,000
+39.35%
|
-
|
|
Mar 01
2022
|
Diego Cadavid Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,000
+48.23%
|
-
|
|
Mar 01
2022
|
Adam S. Mostafa Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,000
+34.63%
|
-
|
|
Mar 01
2022
|
Arthur Taveras Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,000
+48.23%
|
-
|
|
Mar 01
2022
|
Paula Ragan President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
220,789
+24.84%
|
-
|
|
Mar 01
2022
|
Mary Di Biase Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,000
+36.47%
|
-
|
|
Feb 11
2022
|
Diego Cadavid Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
928
-11.55%
|
-
|
|
Feb 11
2022
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
21,695
-4.63%
|
-
|
|
Feb 11
2022
|
Arthur Taveras Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
928
-11.55%
|
-
|
|
Feb 11
2022
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,545
-13.87%
|
-
|
|
Feb 11
2022
|
Derek M Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,909
-21.87%
|
-
|
|
Feb 11
2022
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,721
-22.92%
|
-
|